NCLT Approves Docon-API Holdings Amalgamation; Thyrocare Promoter Holding Unchanged
Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 10:51 pm
NCLT Approves Docon-API Holdings Amalgamation; Thyrocare Promoter Holding Unchanged The National Company Law Tribunal (NCLT) on 31st Aug'26 sanctioned the amalgamation of Docon Technologies with its parent, API Holdings. Consequently, Docon's entire 51.02% stake (81.2M shares) in Thyrocare will be transferred to API Holdings. This internal restructuring within the promoter group results in no change to the aggregate promoter shareholding of 51.02% in Thyrocare. The transaction consolidates the holding under API Holdings, while public shareholding remains unaffected at 48.98%.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. 路 06 Nov 2026
- Please find the enclosed intimation. 路 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 路 02 Nov 2026
- Please find attached Intimation regarding the Execution of Share Purchase Agreement 路 30 Oct 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 路 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find attached the Press Release on the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
